Carregant...
TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
In the past decades, chemotherapy has resulted in improved outcomes for patients with osteosarcoma. However, resistance to chemotherapy often leads to poor prognoses. Cisplatin is a standard drug for osteosarcoma therapy, and chemoresistance to cisplatin in osteosarcoma limits the effectiveness of c...
Guardat en:
| Publicat a: | Int J Mol Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6108886/ https://ncbi.nlm.nih.gov/pubmed/30015899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3753 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|